Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Gaithersburg, MD
SEC filing record 1 source field available
Fiscal year end
31 December
Shuttle Pharmaceuticals Holdings, Inc. has filed 283 SEC EDGAR filings since 31 Jan 2019

SEC filing history

Showing 101-125 of 283 matching filings.

Per page
25
Current page
5
5/A

5/A filing

Filing date
06 Feb 2025
Reporting date
31 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
5/A

5/A filing

Filing date
06 Feb 2025
Reporting date
31 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
5

5 filing

Filing date
05 Feb 2025
Reporting date
31 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
5

5 filing

Filing date
03 Feb 2025
Reporting date
31 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
5

5 filing

Filing date
03 Feb 2025
Reporting date
31 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-284286

424B3 filing

Filing date
24 Jan 2025
Reporting date
Not listed
Next action
Verify source filing
EFFECT File 333-284286

EFFECT filing

Filing date
23 Jan 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
RW File 333-278535

RW filing

Filing date
22 Jan 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
21 Jan 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD File 333-284286

UPLOAD filing

Filing date
21 Jan 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-41488

10-Q filing

Filing date
13 Nov 2024
Reporting date
30 Sep 2024
Next action
Verify source filing
424B4 File 333-282231

424B4 filing

Filing date
31 Oct 2024
Reporting date
Not listed
Next action
Verify source filing
EFFECT File 333-282231

EFFECT filing

Filing date
29 Oct 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .